Call Now

Human DAPK1 / DAP Kinase 1 Protein (aa 1-363, His & GST Tag)

DAPK

Catalog Number P11966-H20B
Organism Species Human
Host Baculovirus-Insect Cells
Synonyms DAPK
Molecular Weight The recombinant human DAPK1 (aa 1-363)/GST chimera consists of 600 amino acids and has a calculated molecular mass of 69.4 kDa. It migrates as an approximately 64 kDa band in SDS-PAGE under reducing conditions.
predicted N Met
SDS-PAGE
Purity > 85 % as determined by SDS-PAGE
Protein Construction A DNA sequence encoding the N-terminal segment of human DAPK1 (P53355-1) (Met 1-Leu 363) was fused with the N-terminal polyhistidine-tagged GST tag at the N-terminus.
Bio-activity The specific activity was determined to be 20 nmol/min/mg using synthetic R11-S6-Peptide (R11-IAKRRRLSSLRASTSKSESSQK) as substrate.
Research Area Signaling |Signal Transduction |Cellular Senescence and Pathways in Aging |Apoptosis |Extracellular Signals |Death Ligands |
Formulation Supplied as sterile 20mM Tris, 500mM NaCl, pH 8.0, 10% gly
1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background Death-associated protein kinase 1, also known as DAP kinase 1, DAPK1 and DAPK, is a cytoplasm protein which belongs to the protein kinase superfamily, CAMK Ser / Thr protein kinase family and DAP kinase subfamily. DAPK1 contains ten ANK repeats, one death domain and one protein kinase domain. DAPK1 is a calcium / calmodulin-dependent serine/threonine kinase which acts as a positive regulator of apoptosis. DAPK1 gene is a candidate tumor suppressor (TSG) and the abnormal methylation of DAPK1 gene has been found in many carcinomas. DAPK1 over-expression can induce cell apoptosis and inhibit tumor cell metastasis. DAPK1 gene over-expression could suppress PGCl3 cells malignant phenotype, inhibit PGCl3 cells growth, invasive, migration and adhesion ability, upregulate p53 gene and downregulate bcl-2 gene. Loss of activity of death-associated protein kinase 1 ( DAPK1 ) may be an independent factor affecting survival of non-small cell lung cancer patients. DAPK1 promoter methylation might play a significant role in the progression of chronic myeloid leukemia ( CML ).
Reference
  • Zhang,H.T. et al., 2004, Ai Zheng. 23 (5):497-501.
  • Martoriati,A. et al., 2005, Oncogene. 24 (8):1461-6.
  • Li,Y. et al., 2006, Hum Mol Genet. 15 (17): 2560-8.
  • Martinez-Glez,V. et al., 2007, Neoplasma. 54 (2):123-6.
  • Raval,A. et al., 2007, Cell. 129 (5):879-90.
  • Gade,P. et al., 2009, Int J Cancer. 125 (7):1566-74.